Trending...
- Boston: Demolition delay application: 1121 Dorchester Ave, Dorchester
- Announcing The Christina Hepburn Breast Cancer Support Campaign
- Boston: Demolition delay application: 14 Euclid Street, Dorchester
TEL AVIV, Israel - BostonChron -- VALFIX Medical Inc. announces today that it has secured its fourth grant from the Israel Innovation Authority. This is the fourth consecutive year that VALFIX Medical is receiving an R&D grant from the Israel Innovation Authority and is the largest amount the company has ever been granted.
This grant is complementary to the company's current Series A investment round. "This grant is a part of our efforts to raise funds for our current series A investment round and secures a significant capital of this round," states Eli Bar, VALFIX Medical CEO. "We know that receiving this grant for the fourth consecutive time sets us apart and validates our ongoing success and accomplishments in our development. We look forward to closing this round and continuing to advance our technology."
This Series A investment round will fund team expansion, production scale up, V&V testing, and first in human clinical study.
More on Boston Chron
VALFIX Medical has received a total of more than 9 million NIS (2.6 million USD) in grants from the Israel Innovation Authority since 2017. Approval for grants from the Israel Innovation Authority requires due diligence and an extensive review of the company's ongoing achievements, progression and execution, assets, and plans.
About VALFIX Medical:
VALFIX Medical has designed an innovative transcatheter system to convert open heart valve surgery to a transcatheter procedure bringing new hope to FMR patients suffering from heart failure.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com
About the Israel Innovation Authority
The Israel Innovation Authority is an independent publicly funded agency, created to provide a variety of practical tools and funding platforms for early-stage entrepreneurs. https://innovationisrael.org.il/en/
This grant is complementary to the company's current Series A investment round. "This grant is a part of our efforts to raise funds for our current series A investment round and secures a significant capital of this round," states Eli Bar, VALFIX Medical CEO. "We know that receiving this grant for the fourth consecutive time sets us apart and validates our ongoing success and accomplishments in our development. We look forward to closing this round and continuing to advance our technology."
This Series A investment round will fund team expansion, production scale up, V&V testing, and first in human clinical study.
More on Boston Chron
- Boston: June 2022: Latest Updates from the Mayor's Office of Housing
- Who Will Be The 2022 Wimbledon Ladies' Champion?
- Ismail Sirdah' Guide To Landing Event Sponsorships
- Massachusetts: Governor Baker Signs Executive Order to Protect Access to Reproductive Health Care Services
- Web Traffic (Visitors) Guidelines: The Ultimate Beginner's Guide
VALFIX Medical has received a total of more than 9 million NIS (2.6 million USD) in grants from the Israel Innovation Authority since 2017. Approval for grants from the Israel Innovation Authority requires due diligence and an extensive review of the company's ongoing achievements, progression and execution, assets, and plans.
About VALFIX Medical:
VALFIX Medical has designed an innovative transcatheter system to convert open heart valve surgery to a transcatheter procedure bringing new hope to FMR patients suffering from heart failure.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com
About the Israel Innovation Authority
The Israel Innovation Authority is an independent publicly funded agency, created to provide a variety of practical tools and funding platforms for early-stage entrepreneurs. https://innovationisrael.org.il/en/
Source: VALFIX Medical
Filed Under: Health
0 Comments
Latest on Boston Chron
- iTech offers 60-days free trial on expEDIum Medical Billing® product
- Boston: Tips for Faster Internet Speeds
- Completion of funding round brings Metaphysiks one step closer to embodying the Metaverse
- On Anniversary of Surfside Tragedy, New Book Coaches Residents to Identify Warning Signs
- Santander Holdings USA, Inc. Provides Statement on Supervisory Stress Test Results
- Boston: The City and B'nai B'rith Housing Celebrate The Residences Off Baker
- Boston: The City and Fenway CDC Celebrate the Acquisition and Renovation of the Newcastle Saranac Apartments
- Boston: BCYF Mirabella Pool Opening Saturday, June 25, 2022
- CHASM unveils highly-respected CEO John Kawola as its first independent board member
- The City of Boston and the Fenway Community Development Corporation Celebrate the Acquisition and Renovation of the Newcastle Saranac Apartments
- The City of Boston and B'nai B'rith Housing Celebrate the Start of Construction on Income Restricted Family Housing
- Boston: Black Community Activism: Melnea Cass's Early Beginnings
- IOTech announces a major new release of Edge XRT, its software platform for time-critical OT systems
- Financial Executives International (FEI) Boston Announces New Board of Directors for 2022-23 Program Year
- Connect Fibre Partners With Linksys and Axiros
- Bacchus Wine & Spirits Jumps To Elite 'Top 20' Position In Beverage Dynamics Top 100 Retailers for 2022
- Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery
- Wheels Up names Todd Smith Chief Financial Officer
- Boston-Based Golden Hearts Games, "The World's First Charity Casino," Surpasses $10M In Donations, Processes Over $6M in 2022 Alone as Over 50,000 Nonprofits Have Now Received Funding From the Platform
- CPC Scientific Announces New California Peptide API Manufacturing Facility